Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Benin
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


   Success Stories

Last Update: 21-10-2013  
Related category(ies):
Agriculture & food  |  Health & life sciences  |  Research policy

 

Countries involved in the project described in the article:
Austria  |  Belgium  |  Denmark  |  Finland  |  France  |  Germany  |  Greece  |  Italy  |  Netherlands  |  Norway  |  Poland  |  Portugal  |  Spain  |  Sweden  |  Switzerland  |  United Kingdom
Add to PDF "basket"

Tackling allergies through collaborative research and education

The EU-funded Global Allergy and Asthma European Network (GA²LEN), launched in 2004, has become a leading force in the battle against allergic diseases. The network is still expanding, with over 60 centres in more than 20 European countries.

©  Zlatan Durakovic - Fotolia.com

Indeed, the latest addition to the network is Ospedale Pediatrico Bambino Gesù, a unit specialising in rhinitis, bronchial asthma and allergic conjunctivitis, located in the Vatican City. By bringing together centres of excellence like this, the network aims to accelerate the application of research results in clinical practice.

There is certainly a need for action. Allergies can be fatal. Asthma, a common inflammation of the airways that can be triggered by allergens, kills someone in Europe every hour, says the World Health Organisation (WHO).

Allergy sufferers also experience major inconveniences in their daily lives. For example, children often have to miss school or stop doing sport, and breathing and skin problems can dent confidence.

The problem is not going away. According to the European Federation of Allergy and Airways Diseases Patients' Associations, asthma alone accounts for an estimated nine billion work days lost in the EU annually. GA²LEN researchers estimate that allergies cost the EU economy some EUR 100 billion a year.

The GA²LEN Network seeks to help by integrating European research activities and encouraging better cooperation among those working in the field. The researchers also compiled a European database of comparable studies – known as cohorts. In the future, this should help scientists conduct more reliable analyses of the genetic and environmental factors that cause allergies.

The project has also established a network of ‘allergy schools‘, in collaboration with the European Academy of Allergology and Clinical Immunology (EAACI). These schools, which take place in winter and summer, aim to stimulate social contacts between young people interested in allergy and clinical immunology.

The courses are organised together with the EAACI national membership society of each host country. These include lectures on epidemiology – the study of disease patterns within populations, risk factors, diagnostics and treatments. Interactive practical demonstrations of skin tests and immunotherapy are also carried out.

Finally, the network aims to raise the profile of allergies at the European policy level, pushing the issue to the top of the agenda. While progress has been made, further collaborative research is necessary to fully understand the problem.

For example, GA²LEN partners are currently trying to work out why children brought up on farms, or babies fed on unpasteurised fresh milk, are far less likely to develop allergies.

Furthermore, GA²LEN is strongly supporting initiatives for a better understanding of emerging allergy trends throughout Europe as presently, not even pollen counts are being analysed for all regions.

The GA²LEN project, which was coordinated by the University of Ghent, Belgium, was completed in January 2010. The EU provided EUR 14 million in funding.

Project details

  • Project acronym:
  • Participants: Belgium (Coordinator), France, Germany, Spain, United Kingdom, Poland, Switzerland, Netherlands, Sweden, Denmark, Greece, Italy, Portugal, Finland, Norway, Austria
  • Project FP6 506378
  • Total costs: €14 400 000
  • Duration: February 2004 - January 2010

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site
Project information on CORDIS





  Top   Research Information Center